Prognostic and immunotherapeutic response prediction in hepatocellular carcinoma: role of non-histone acetylation/deacetylation scoring
Abstract Background Post-translational modification is crucial, with acetylation and deacetylation enzymes playing important roles. Their roles in liver cancer, however, remain unclear. Methods In this study, a KAT + KDAC score was developed to assess the prognosis and response to immunotherapy in l...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-08-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03339-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849764405514862592 |
|---|---|
| author | Jizhen Li Sisi Huang Fangling Yuan Xunjun Yang Qipeng Xie |
| author_facet | Jizhen Li Sisi Huang Fangling Yuan Xunjun Yang Qipeng Xie |
| author_sort | Jizhen Li |
| collection | DOAJ |
| description | Abstract Background Post-translational modification is crucial, with acetylation and deacetylation enzymes playing important roles. Their roles in liver cancer, however, remain unclear. Methods In this study, a KAT + KDAC score was developed to assess the prognosis and response to immunotherapy in liver cancer patients. The association of HDAC1, HDAC2, and HDAC3 with patient prognosis was analyzed, and the PPI network was constructed. The correlation between the score and P53 mutation status, stage, and TNM staging was also investigated. Additionally, the response to chemotherapy was evaluated. The TIDE score was also assessed. Results Our analysis showed that HDAC1, HDAC2, and HDAC3 are highly associated with patient prognosis and are centrally located in the PPI network. Patients with high KAT + KDAC scores had a better prognosis, and the score correlated with P53 mutation status, stage, and TNM staging. Notably, patients with low KAT + KDAC scores demonstrate resistance to cisplatin and gemcitabine, and have a lower TIDE score. Moreover, the KAT + KDAC score accurately predicted patient response to immunotherapy. Conclusion The KAT + KDAC modification pattern is critical in the initiation and progression of liver cancer. This score can be used to predict patient prognosis and immunotherapy response. Future studies are needed to further explore the underlying mechanisms and potential therapeutic applications. |
| format | Article |
| id | doaj-art-05347a62df074fb89a48fafcde8309ca |
| institution | DOAJ |
| issn | 2730-6011 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Oncology |
| spelling | doaj-art-05347a62df074fb89a48fafcde8309ca2025-08-20T03:05:09ZengSpringerDiscover Oncology2730-60112025-08-0116112110.1007/s12672-025-03339-9Prognostic and immunotherapeutic response prediction in hepatocellular carcinoma: role of non-histone acetylation/deacetylation scoringJizhen Li0Sisi Huang1Fangling Yuan2Xunjun Yang3Qipeng Xie4Department of Clinical Laboratory, The Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical UniversityDepartment of Pathology, The First Affiliated Hospital of Wenzhou Medical UniversityDepartment of Clinical Laboratory, The Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical UniversityDepartment of Clinical Laboratory, The Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical UniversityDepartment of Clinical Laboratory, The Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical UniversityAbstract Background Post-translational modification is crucial, with acetylation and deacetylation enzymes playing important roles. Their roles in liver cancer, however, remain unclear. Methods In this study, a KAT + KDAC score was developed to assess the prognosis and response to immunotherapy in liver cancer patients. The association of HDAC1, HDAC2, and HDAC3 with patient prognosis was analyzed, and the PPI network was constructed. The correlation between the score and P53 mutation status, stage, and TNM staging was also investigated. Additionally, the response to chemotherapy was evaluated. The TIDE score was also assessed. Results Our analysis showed that HDAC1, HDAC2, and HDAC3 are highly associated with patient prognosis and are centrally located in the PPI network. Patients with high KAT + KDAC scores had a better prognosis, and the score correlated with P53 mutation status, stage, and TNM staging. Notably, patients with low KAT + KDAC scores demonstrate resistance to cisplatin and gemcitabine, and have a lower TIDE score. Moreover, the KAT + KDAC score accurately predicted patient response to immunotherapy. Conclusion The KAT + KDAC modification pattern is critical in the initiation and progression of liver cancer. This score can be used to predict patient prognosis and immunotherapy response. Future studies are needed to further explore the underlying mechanisms and potential therapeutic applications.https://doi.org/10.1007/s12672-025-03339-9AcetylationDeacetylationConsistent clusteringImmunotherapyPrognosis |
| spellingShingle | Jizhen Li Sisi Huang Fangling Yuan Xunjun Yang Qipeng Xie Prognostic and immunotherapeutic response prediction in hepatocellular carcinoma: role of non-histone acetylation/deacetylation scoring Discover Oncology Acetylation Deacetylation Consistent clustering Immunotherapy Prognosis |
| title | Prognostic and immunotherapeutic response prediction in hepatocellular carcinoma: role of non-histone acetylation/deacetylation scoring |
| title_full | Prognostic and immunotherapeutic response prediction in hepatocellular carcinoma: role of non-histone acetylation/deacetylation scoring |
| title_fullStr | Prognostic and immunotherapeutic response prediction in hepatocellular carcinoma: role of non-histone acetylation/deacetylation scoring |
| title_full_unstemmed | Prognostic and immunotherapeutic response prediction in hepatocellular carcinoma: role of non-histone acetylation/deacetylation scoring |
| title_short | Prognostic and immunotherapeutic response prediction in hepatocellular carcinoma: role of non-histone acetylation/deacetylation scoring |
| title_sort | prognostic and immunotherapeutic response prediction in hepatocellular carcinoma role of non histone acetylation deacetylation scoring |
| topic | Acetylation Deacetylation Consistent clustering Immunotherapy Prognosis |
| url | https://doi.org/10.1007/s12672-025-03339-9 |
| work_keys_str_mv | AT jizhenli prognosticandimmunotherapeuticresponsepredictioninhepatocellularcarcinomaroleofnonhistoneacetylationdeacetylationscoring AT sisihuang prognosticandimmunotherapeuticresponsepredictioninhepatocellularcarcinomaroleofnonhistoneacetylationdeacetylationscoring AT fanglingyuan prognosticandimmunotherapeuticresponsepredictioninhepatocellularcarcinomaroleofnonhistoneacetylationdeacetylationscoring AT xunjunyang prognosticandimmunotherapeuticresponsepredictioninhepatocellularcarcinomaroleofnonhistoneacetylationdeacetylationscoring AT qipengxie prognosticandimmunotherapeuticresponsepredictioninhepatocellularcarcinomaroleofnonhistoneacetylationdeacetylationscoring |